MASI Key Statistics, Chart & Performance
The current stock price of MASI is 138.92 USD. In the past month the price decreased by -0.61%. In the past year, price decreased by -16.52%.
MASI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.23 | 218.96B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.09 | 207.82B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.1 | 144.75B | ||
| SYK | STRYKER CORP | 27.91 | 140.55B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.87B | ||
| IDXX | IDEXX LABORATORIES INC | 56.57 | 56.96B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.02 | 39.76B | ||
| RMD | RESMED INC | 25.5 | 36.85B | ||
| DXCM | DEXCOM INC | 36.24 | 26.29B | ||
| PODD | INSULET CORP | 63.25 | 20.33B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.48 | 18.40B |
Related stock screener links
About MASI
Company Profile
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 3,600 full-time employees. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Company Info
MASIMO CORP
52 Discovery
Irvine CALIFORNIA 92618 US
CEO: Joe Kiani
Employees: 3600
Phone: 19492977000
MASIMO CORP / MASI FAQ
What does MASI do?
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 3,600 full-time employees. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Can you provide the latest stock price for MASIMO CORP?
The current stock price of MASI is 138.92 USD. The price increased by 0.73% in the last trading session.
What is the dividend status of MASIMO CORP?
MASI does not pay a dividend.
What is the ChartMill rating of MASIMO CORP stock?
MASI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Is MASIMO CORP (MASI) expected to grow?
The Revenue of MASIMO CORP (MASI) is expected to decline by -27.11% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for MASIMO CORP?
MASIMO CORP (MASI) currently has 3600 employees.
What is MASIMO CORP worth?
MASIMO CORP (MASI) has a market capitalization of 7.46B USD. This makes MASI a Mid Cap stock.
MASI Technical Analysis
MASI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MASI. MASI has only an average score on both its financial health and profitability.
MASI Financial Highlights
Over the last trailing twelve months MASI reported a non-GAAP Earnings per Share(EPS) of 5.68. The EPS increased by 54.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.33% | ||
| ROE | -70.3% | ||
| Debt/Equity | 0.69 |
MASI Forecast & Estimates
16 analysts have analysed MASI and the average price target is 187.2 USD. This implies a price increase of 34.75% is expected in the next year compared to the current price of 138.92.
For the next year, analysts expect an EPS growth of 30.61% and a revenue growth -27.11% for MASI